Preliminary experiments indicate conolidine may perhaps inhibit unique ion channels, lowering neuronal excitability and restricting agony indicators. This system is particularly relevant in neuropathic suffering, where irregular signaling brings about persistent discomfort. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways